Patil Rajkumar V.'s Form 4 filing
OKYO Pharma Ltd (OKYO) · filed Jul 29, 2026
- Accession no.
- 0001493152-26-035212
- Filed
- Jul 29, 2026, 4:45 PM ET
- Trade date
- Jul 27, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. It was filed 2 days after the trade.
This filing was later replaced by the amendment 0001493152-26-036581 (Aug 7, 2026). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patil Rajkumar V.CIK 0002124067 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | COMMON STOCK | AGrant or awardAcquired | +3,363 | $1.49 | +$5,010.87 | 20,030 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.